Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction

NCT05217654 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Reperfusion Injury
Vascular Complications

Interventions

DRUG: Dapagliflozin 10mg
DRUG: Placebo

Sponsor

Medical University of Vienna